AVRA Medical Robotics, Inc.

Symbol: AVMR

PNK

9.17

USD

Market price today

  • -185.4370

    P/E Ratio

  • 1.6234

    PEG Ratio

  • 494.15M

    MRK Cap

  • 0.00%

    DIV Yield

AVRA Medical Robotics, Inc. (AVMR) Financial Statements

On the chart you can see the default numbers in dynamics for AVRA Medical Robotics, Inc. (AVMR). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of AVRA Medical Robotics, Inc., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016

balance-sheet.row.cash-and-short-term-investments

8.911.40.40.2
0
0
0.5
0.2

balance-sheet.row.short-term-investments

0000
0
0
0
0

balance-sheet.row.net-receivables

10.61300
0
0
0
0

balance-sheet.row.inventory

-3.83-300
0
0
0
0

balance-sheet.row.other-current-assets

15.09300
0
0
0
0

balance-sheet.row.total-current-assets

30.784.40.40.2
0
0
0.5
0.2

balance-sheet.row.property-plant-equipment-net

0.7000
0.1
0
0
0

balance-sheet.row.goodwill

0000
0
0
0
0

balance-sheet.row.intangible-assets

0000
0
0.1
0
0

balance-sheet.row.goodwill-and-intangible-assets

0000
0
0.1
0
0

balance-sheet.row.long-term-investments

0000.1
0
0
0
0

balance-sheet.row.tax-assets

000-0.2
0
0
0
0

balance-sheet.row.other-non-current-assets

4.07000.2
0
0
0
0

balance-sheet.row.total-non-current-assets

4.77000.2
0.1
0.1
0
0

balance-sheet.row.other-assets

0000
0
0
0
0

balance-sheet.row.total-assets

35.554.40.40.3
0.1
0.1
0.5
0.3

balance-sheet.row.account-payables

0.2400.10.1
0.1
0
0
0.1

balance-sheet.row.short-term-debt

10.2440.10.2
0.5
0
0
0.5

balance-sheet.row.tax-payables

0000
0
0
0
0

balance-sheet.row.long-term-debt-total

0000
0
0
0
0

Deferred Revenue Non Current

0000
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0.01---
-
-
-
-

balance-sheet.row.other-current-liab

8.30.100.9
0.6
0.1
0.4
0.1

balance-sheet.row.total-non-current-liabilities

1.32000
0
0
0
0

balance-sheet.row.other-liabilities

-1.32000
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
0
0

balance-sheet.row.total-liab

18.784.10.31.2
1.2
0.4
0.4
0.6

balance-sheet.row.preferred-stock

0000
0
0
0
0

balance-sheet.row.common-stock

0.4900.50.1
0.3
0
0
0

balance-sheet.row.retained-earnings

-53.99-10.7-8.5-7
-5.9
-2.5
-1.5
-0.5

balance-sheet.row.accumulated-other-comprehensive-income-loss

0.9000
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

69.36118.26
4.5
2.2
1.6
0.1

balance-sheet.row.total-stockholders-equity

16.760.30.1-0.9
-1.1
-0.3
0.1
-0.4

balance-sheet.row.total-liabilities-and-stockholders-equity

35.554.40.40.3
0.1
0.1
0.5
0.3

balance-sheet.row.minority-interest

0000
0
0
0
0

balance-sheet.row.total-equity

16.760.30.1-0.9
-1.1
-0.3
0.1
-0.4

balance-sheet.row.total-liabilities-and-total-equity

35.55---
-
-
-
-

Total Investments

0000.1
0
0
0
0

balance-sheet.row.total-debt

10.2440.10.2
0.5
0
0
0.5

balance-sheet.row.net-debt

1.332.6-0.30
0.4
0
-0.5
0.2

Cash Flow Statement

The financial landscape of AVRA Medical Robotics, Inc. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016

cash-flows.row.net-income

-4.14-2.2-1.5-1.1
-3.4
-1
-1
-0.5

cash-flows.row.depreciation-and-amortization

0.01000
0
0
0
0

cash-flows.row.deferred-income-tax

0.100.10
0.1
0
0
0

cash-flows.row.stock-based-compensation

2.430.90.80.4
1.1
0.2
0.3
0.1

cash-flows.row.change-in-working-capital

-0.02-0.1-0.80.5
0.4
0.3
0.3
0.1

cash-flows.row.account-receivables

0000
0
0
0
0

cash-flows.row.inventory

0000
0
0
0
0

cash-flows.row.account-payables

-0.09-0.100
0
0
0
0

cash-flows.row.other-working-capital

0.08000
0
0
0
0

cash-flows.row.other-non-cash-items

-0.101.10
1.4
0
0
0

cash-flows.row.net-cash-provided-by-operating-activities

-1.71000
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0000
-0.1
0
0
0

cash-flows.row.acquisitions-net

0000
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0
0

cash-flows.row.other-investing-activites

-5-300
0
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

-5-300
-0.1
0
0
0

cash-flows.row.debt-repayment

0-0.10-0.1
0
0
0
0

cash-flows.row.common-stock-issued

1.91.50.60.2
0
0
0.7
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0

cash-flows.row.other-financing-activites

4.91400.1
0
0
0
0.5

cash-flows.row.net-cash-used-provided-by-financing-activities

6.825.40.60.3
0.5
0.1
0.7
0.5

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0

cash-flows.row.net-change-in-cash

0.10.90.20.1
0
-0.4
0.2
0.2

cash-flows.row.cash-at-end-of-period

2.581.40.40.2
0
0
0.5
0.2

cash-flows.row.cash-at-beginning-of-period

2.470.40.20
0
0.5
0.2
0

cash-flows.row.operating-cash-flow

-1.71-1.4-0.4-0.1
-0.4
-0.4
-0.4
-0.2

cash-flows.row.capital-expenditure

0000
-0.1
0
0
0

cash-flows.row.free-cash-flow

-1.71-1.4-0.4-0.1
-0.5
-0.5
-0.5
-0.3

Income Statement Row

AVRA Medical Robotics, Inc.'s revenue saw a change of NaN% compared with the previous period. The gross profit of AVMR is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016

income-statement-row.row.total-revenue

3.01000
0
0
0
0

income-statement-row.row.cost-of-revenue

2.62000
0
0
0
0

income-statement-row.row.gross-profit

0.38000
0
0
0
0

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0

income-statement-row.row.research-development

0.07---
-
-
-
-

income-statement-row.row.selling-general-administrative

3.28---
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-

income-statement-row.row.other-expenses

0.170.300
0
0
0
0

income-statement-row.row.operating-expenses

6.612.41.41.1
3.3
1
1
0.5

income-statement-row.row.cost-and-expenses

9.232.41.41.1
3.3
1
1
0.5

income-statement-row.row.interest-income

0000
0
0
0
0

income-statement-row.row.interest-expense

0.11000
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-0.330-0.10
-0.1
0
0
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-

income-statement-row.row.other-operating-expenses

0.170.300
0
0
0
0

income-statement-row.row.total-operating-expenses

-0.330-0.10
-0.1
0
0
0

income-statement-row.row.interest-expense

0.11000
0
0
0
0

income-statement-row.row.depreciation-and-amortization

0000
0
0
0
0

income-statement-row.row.ebitda-caps

-6.68---
-
-
-
-

income-statement-row.row.operating-income

-6.69-2.2-1.4-1.1
-3.3
-1
-1
-0.5

income-statement-row.row.income-before-tax

-7.01-2.2-1.5-1.1
-3.4
-1
-1
-0.5

income-statement-row.row.income-tax-expense

1.382.200
0
0
0
0

income-statement-row.row.net-income

-8.39-4.4-1.5-1.1
-3.4
-1
-1
-0.5

Frequently Asked Question

What is AVRA Medical Robotics, Inc. (AVMR) total assets?

AVRA Medical Robotics, Inc. (AVMR) total assets is 4371441.000.

What is enterprise annual revenue?

The annual revenue is 3005078.000.

What is firm profit margin?

Firm profit margin is 0.128.

What is company free cash flow?

The free cash flow is -0.009.

What is enterprise net profit margin?

The net profit margin is -2.791.

What is firm total revenue?

The total revenue is -2.225.

What is AVRA Medical Robotics, Inc. (AVMR) net profit (net income)?

The net profit (net income) is -4380495.000.

What is firm total debt?

The total debt is 4000000.000.

What is operating expences number?

The operating expences are 2447606.000.

What is company cash figure?

Enretprise cash is 6596224.000.